PAPER 2026 SOLVED QUESTIONS WITH FULL
SOLUTION ALREADY PASSED
◉ Schedule I.
Answer: Drugs with high abuse potential, no medical use.
◉ Schedule III.
Answer: Drugs with lesser abuse potential than Schedule II.
◉ Schedule IV.
Answer: Drugs with low abuse potential and limited dependence.
◉ Phase III studies.
Answer: Involve vast clinical populations for drug evaluation.
◉ Bioavailability.
Answer: Portion of drug reaching systemic circulation effectively.
◉ Critical concentration.
Answer: Amount of drug needed for therapeutic effect.
,◉ Distribution.
Answer: Movement of drug to body tissues in pharmacokinetics.
◉ Half-life.
Answer: Time for drug amount to decrease by half.
◉ Adverse effects.
Answer: Negative reactions experienced by patients during drug use.
◉ FDA.
Answer: Food and Drug Administration, regulates drug approval.
◉ Generic drugs.
Answer: Medications equivalent to brand-name drugs in dosage.
◉ Brand name drugs.
Answer: Medications marketed under a trademarked name.
◉ Narcotics.
Answer: Drugs with high potential for abuse and dependence.
,◉ Clinical population.
Answer: Group of patients involved in drug studies.
◉ Preclinical trials.
Answer: Initial drug testing phase using animal subjects.
◉ Drug evaluation studies.
Answer: Research to assess drug safety and effectiveness.
◉ Medication safety.
Answer: Assessment of drug interactions and patient health.
◉ Over-the-counter medications.
Answer: Drugs available without prescription.
◉ Orphan drugs.
Answer: Medications for rare diseases with limited market.
◉ Patient monitoring.
Answer: Observing patients for drug effects and safety.
◉ Experimental drugs.
, Answer: Medications under investigation for efficacy and safety.
◉ Over-the-Counter Medications.
Answer: Medications patients may underestimate in importance.
◉ Orphan Drugs.
Answer: Medications for rare diseases, often unknown to patients.
◉ Pharmacology Course Completion.
Answer: Nurses gain knowledge for safe medication administration.
◉ Continuing Education.
Answer: Essential for staying updated on pharmacology changes.
◉ Drug Guide Consultation.
Answer: Necessary for specific drug information before
administration.
◉ Pregnancy Category B.
Answer: Animal studies show no fetal risk; human studies lacking.
◉ Pregnancy Category A.